Karan Mediratta
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer.
Journal: Nanomaterials (Basel, Switzerland)
Published: March 16, 2026
Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity.
Journal: Molecular therapy. Oncology
Published: December 16, 2025
Emerging Strategies for Cargo Loading and Engineering of Extracellular Vesicles for Breast Cancer Treatment.
Journal: Nanomaterials (Basel, Switzerland)
Published: August 10, 2025
Nanoparticles Codelivering mRNA and SiRNA for Simultaneous Restoration and Silencing of Gene/Protein Expression In Vitro and In Vivo.
Journal: ACS nanoscience Au
Published: July 13, 2024
Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.
Journal: Frontiers in immunology
Published: January 05, 2024
A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy.
Journal: Journal of extracellular vesicles
Published: March 20, 2023
Applications of Extracellular Vesicles in Triple-Negative Breast Cancer.
Journal: Cancers
Published: December 15, 2021
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer.
Journal: Cancers
Published: November 05, 2020
Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells.
Journal: International journal of molecular sciences
Published: July 21, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026